Quynh-Thu Xuan Le MD FASTRO

Radiation Oncology•Stanford, CA

Head & Neck

Professor, Radiation Oncology, Stanford University Medical Center

Join to View Full Profile

300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-725-8231

Summary

Dr. Quynh-Thu Le is a radiation oncologist in Stanford, CA and is affiliated with multiple hospitals in the area, including Lucile Packard Children's Hospital Stanford, Stanford Health Care, and VA Palo Alto Health Care System. She received her medical degree from University of California San Francisco School of Medicine and has been in practice 24 years. She specializes in head & neck.

Education & Training

University of California (San Francisco)Residency, Radiation Oncology, 1994 - 1997
Alameda Health System-Highland HospitalInternship, Transitional Year, 1993 - 1994
University of California San Francisco School of MedicineClass of 1993

Certifications & Licensure

CA State Medical License 1994 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2014
America's Top Doctors for Cancer Castle Connolly, 2007-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer Start of enrollment: 2000 Oct 01
Completed
Phase 1
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Sep 01
Completed
Phase 2
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck Start of enrollment: 2002 Jun 01
Completed
Phase 1
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers Start of enrollment: 2000 Sep 01
Completed
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations Start of enrollment: 2001 Nov 01
Completed
Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers Start of enrollment: 2003 Apr 01
Completed
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers Start of enrollment: 2003 May 01
Completed
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast Start of enrollment: 2003 Feb 01
Completed
Not Applicable
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer Start of enrollment: 2002 Apr 02
RECRUITING
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
RECRUITING
Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Start of enrollment: 2007 Jul 01
Terminated
Phase 2
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers Start of enrollment: 1998 Sep 01
RECRUITING
Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer Start of enrollment: 2009 Oct 01
Terminated
Not Applicable
Imaging and Biomarkers of Hypoxia in Solid Tumors Start of enrollment: 2010 Dec 01
Terminated
Phase 1
Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers Start of enrollment: 2010 Aug 01
Completed
Phase 1
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
RECRUITING
PHASE2, PHASE3
Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery Start of enrollment: 2016 Feb 01
Completed
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxx.
Christina L Runge, Jessica A Lyness, Maura L Gillison, David J Adelstein, Paul M Harari
International Journal of Radiation Oncology, Biology, Physics. 2025-08-17
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination with Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the ...
Corey J Langer, Jonathan Harris, Eric M Horwitz, Merrill Kies, Voichita Bar Ad
International Journal of Radiation Oncology, Biology, Physics. 2025-07-31
1 citations
Automated radiotherapy treatment planning guided by GPT-4Vision.
Sheng Liu, Oscar Pastor-Serrano, Yizheng Chen, Matthew Gopaulchan, Weixing Liang
Physics in Medicine and Biology. 2025-07-24

Journal Articles

International Guideline for the Delineation of the Clinical Target Volumes (CTV) for Nasopharyngeal Carcinoma
William M. Mendenhall, Qunyh-Thu Le, Nancy Y. Lee, Radiotherapy & Oncology

Press Mentions

Pioneering Precision: GE HealthCare Aims to Elevate Clinical Care Through Total Body PET/CT Technology with Stanford MedicineJune 19th, 2025
Stanford Medicine Department of Radiology to Continue Advancements in Molecular Imaging with New Long Axial Field of View PET/CT Technology with GE HealthCareJune 19th, 2025
RSNA 2022 Plenaries Highlight Radiology’s Value, Responsibility to PatientsJuly 19th, 2022
Join now to see all

Grant Support

Molecular Strategies to Widen the Therapeutic Index of RadiotherapySTANFORD UNIVERSITY2022–2027
Precision imaging for risk stratification and personalized therapy of oropharyngeal cancerSTANFORD UNIVERSITY2022–2027
The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancerSTANFORD UNIVERSITY2021–2026
NRG Oncology Network Group Operations CenterNRG ONCOLOGY FOUNDATION, INC.2014–2025
NRG Oncology Network Group Operations CenterNRG ONCOLOGY FOUNDATION, INC.2014–2025
Targeting Galectin-1 With Radiation In Lung CancerNational Cancer Institute2012
A Novel Therapy For Radiation-Induced Xerostomia Using Human Salivary Stem CellsNational Institute Of Dental &Craniofacial Research2011
Osteopontin &Tumor Progression In Head And Neck CancersNational Cancer Institute2007–2011
Defining Molecular Markers For Tumor HypoxiaNational Cancer Institute2006–2010
Markers For Tumor Hypoxia In Head And Neck CancerNational Cancer Institute2001–2002